Stock Highlights: Randgold Resources Limited (NASDAQ:GOLD), Stemline Therapeutics, Inc. (NASDAQ:STML), Coty Inc. (NYSE:COTY), Sanofi SA (ADR) (NYSE:SNY), Inter Parfums Inc. (NASDAQ:IPAR)

Randgold Resources Ltd. (NASDAQ:GOLD) was downgraded by stock analysts at Bank of America from a “buy” rating to a “neutral” rating in a report issued on Tuesday, The Fly reports.

Randgold Resources Limited (NASDAQ:GOLD) belongs to Basic Materials sector. Its net profit margin is 18.80% and weekly performance is 1.82%. On last trading day company shares ended up at $91.01.

Stemline Therapeutics, Inc. (NASDAQ:STML), announced that Ivan Bergstein, M.D., Stemline’s CEO, will present at the Cowen and Company 36th Annual Health Care Conference on Wednesday, March 9, 2016 at 8:40 AM ET. The conference is being held at the Boston Marriot Copley Place in Boston, MA.

Stemline Therapeutics, Inc. (NASDAQ:STML) shares advanced 2.90% in last trading session and ended the day at $5.68. STML return on assets is -34.50%. Stemline Therapeutics, Inc. (NASDAQ:STML) quarterly performance is -28.82%.

Levi & Korsinsky announces it has commenced an investigation of Coty Inc. (NYSE:COTY) concerning possible breaches of fiduciary duty by the board of directors of the company.

On 04 March, Coty Inc. (NYSE:COTY) shares decreased -1.74% and was closed at $27.62. COTY EPS growth in last 5 year was 23.80%. Coty Inc. (NYSE:COTY) year to date (YTD) performance is 7.76%.

Sanofi (NYSE: SNY) and its specialty care global business unit Sanofi Genzyme presented data from NEO1, its Phase 1/2 clinical study evaluating the investigational novel enzyme replacement therapy neoGAA in 24 patients with late-onset Pompe disease. The safety and efficacy data from this study, which were presented at WORLDSymposium 2016 in San Diego, CA, support further development of the therapy. Sanofi Genzyme plans to begin enrolling patients in a pivotal Phase 3 trial for neoGAA in Q2 2016.

Sanofi SA (ADR) (NYSE:SNY) ended the last trading day at $39.81. Company weekly volatility is calculated as 1.46% and price to cash ratio as 10.33. Sanofi SA (ADR) (NYSE:SNY) showed a weekly performance of -0.85%.

Inter Parfums, Inc. (NASDAQ: IPAR) announced that it will issue financial results for the fourth quarter ended December 31, 2015 on Monday, March 14, 2016 before the stock market opens.

Inter Parfums Inc. (NASDAQ:IPAR) shares advanced 0.86% in last trading session and ended the day at $27.08. IPAR Gross Margin is 60.60% and its return on assets is 5.00%. Inter Parfums Inc. (NASDAQ:IPAR) quarterly performance is 3.21%.

Leave a Reply

Your email address will not be published. Required fields are marked *